?6+3F|B*C:{5@3T=28A^
SYSTEM PROCESSING...
?6+3F|B*C:{5@3T=28A^
SYSTEM PROCESSING...
Posted: 2025-05-11 19:48:32 UTC
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
Status
Last Updated
2025-05-11 19:48:38 UTC
Verified By
Rollup News
PRL3-zumab, a novel antibody therapy, targets an intracellular protein in solid tumors, showing promise in slowing disease progression in advanced cancers resistant to standard treatments.
Novel antibody therapy targeting intracellular protein
Targets most solid tumors
Slows disease progression in advanced cancers
Effective in cancers unresponsive to standard treatments
Advanced cancers unresponsive to standard treatments